The share

Inify Laboratories AB is listed on Euronext Growth Oslo since June 20th, 2022. All shares have equal rights and are freely transferable. Please follow the development of the Inify Laboratories share on Euronext Growth and view stock exchange releases at NewsWeb.

Share information

Ticker code
Number of shares
Trading currency
Sector
ISIN
LEI code

INIFY
45,236,750
NOK
Health care
SE0017486103
549300306YYJ3BX3VB98

Shareholders

Inify Laboratories AB is listed on Euronext Growth Oslo under the ticker INIFY.
The list of total shares and the 20 largest shareholders is updated monthly, usually at month end. The last update was made on February 1st 2023. The company has a total of 45,236,750 outstanding shares.

20 largest shareholders

Number of shares heldOwnership (%)Shareholder
27 183 72660,09%Gallivant S.á.r.l.
4 591 41210,15%Tauri AS
1 964 7684,34%Günther-Hanssen, Sven
1 872 4144,14%MP Pensjon PK
1 872 2094,14%Danske Bank A/S
894 5431,98%Bras Kapital AS
708 2141,57%Stavland, Bernt
648 1671,43%Stavland, Anders
434 3160,96%Swedbank AB
427 5680,95%Stavland, Per
336 9500,74%Monsun AS
332 9710,74%Vinterstua AS
309 9220,69%Avanza Bank AB
245 0000,54%Olsen, Lars Ejnar
200 0000,44%Sveen, Kristian
172 6970,38%Danske Bank A/S
171 0160,38%Skandinaviska Enskilda Banken AB
166 2310,37%Skjelbred, Rune
141 0390,31%B Stavland Holding AS
97 0930,21%Svenska Handelsbanken AB
2 466 4945,45%Others
45 236 750100,00%Total

Primary Insider Transactions

Information about primary insider transactions can be found under Investor news.

Dividend policy

The board of Inify Laboratories AB has not adopted a dividend policy since the Company considers itself to be in a growth phase, and therefore does not foresee that it will pay dividends in the near future. In deciding whether to propose a dividend and in determining the dividend amount, the Board of Directors will take into account legal restrictions as well as capital expenditure plans, financing requirements and maintaining the appropriate strategic flexibility.